Molecular Abnormalities in Ovarian Cancer Subtypes Other than High-Grade Serous Carcinoma

por Gilks, C. Blake
Publicado 2010

Ovarian carcinoma histotype in Lynch syndrome

por Gilks, C. Blake, Clarke, Blaise A., Foulkes, William D.
Publicado 2017

Ovarian carcinoma diagnosis: the clinical impact of 15 years of change

por Kommoss, Stefan, Gilks, C Blake, du Bois, Andreas, Kommoss, Friedrich
Publicado 2016

Patterns of spread of clear cell ovarian cancer: Case report and case series()

por Kumar, Aalok, Gilks, C. Blake, Mar, Colin, Santos, Jennifer, Tinker, Anna V.
Publicado 2013

Modeling Canadian Quality Control Test Program for Steroid Hormone Receptors in Breast Cancer: Diagnostic Accuracy Study

por Pérez, Teresa, Makrestsov, Nikita, Garatt, John, Torlakovic, Emina, Gilks, C. Blake, Mallett, Susan
Publicado 2016

Low grade serous carcinoma of the peritoneum in a BRCA1 carrier previously diagnosed with a “low-grade serous tubal intra-epithelial carcinoma” (STIC) on risk reducing surgery

por Chay, Wen Yee, Horlings, Hugo M., Tinker, Anna V., Gelmon, Karen A., Gilks, C.Blake
Publicado 2015

Interpretation of P53 Immunohistochemistry in Endometrial Carcinomas: Toward Increased Reproducibility

por Köbel, Martin, Ronnett, Brigitte M., Singh, Naveena, Soslow, Robert A., Gilks, C. Blake, McCluggage, W. Glenn
Publicado 2019

Gross genomic alterations and gene expression profiles of high- grade serous carcinoma of the ovary with and without BRCA1 inactivation

por Pradhan, Manohar, Risberg, Björn Å, Tropé, Claes G, van de Rijn, Matt, Gilks, C Blake, Lee, Cheng-Han
Publicado 2010

Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors

por Milne, Katy, Köbel, Martin, Kalloger, Steven E., Barnes, Rebecca O., Gao, Dongxia, Gilks, C. Blake, Watson, Peter H., Nelson, Brad H.
Publicado 2009

Correction: Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors

por Milne, Katy, Köbel, Martin, Kalloger, Steven E., Barnes, Rebecca O., Gao, Dongxia, Gilks, C. Blake, Watson, Peter H., Nelson, Brad H.
Publicado 2013

Tumor Staging of Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists

por Park, Kay J., Roma, Andres, Singh, Naveena, Gilks, C. Blake, Oliva, Esther, Abu-Rustum, Nadeem, Ramirez, Pedro T., McCluggage, W. Glenn
Publicado 2021

Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases

por Rajput, Ashish B., Turbin, Dmitry A., Cheang, Maggie CU, Voduc, David K., Leung, Sam, Gelmon, Karen A., Gilks, C. Blake, Huntsman, David G.
Publicado 2007

The cell surface mucin podocalyxin regulates collective breast tumor budding

por Graves, Marcia L., Cipollone, Jane A., Austin, Pamela, Bell, Erin M., Nielsen, Julie S., Gilks, C. Blake, McNagny, Kelly M., Roskelley, Calvin D.
Publicado 2016

MicroRNA Profiling of BRCA1/2 Mutation-Carrying and Non-Mutation-Carrying High-Grade Serous Carcinomas of Ovary

por Lee, Cheng-Han, Subramanian, Subbaya, Beck, Andrew H., Espinosa, Inigo, Senz, Janine, Zhu, Shirley X., Huntsman, David, van de Rijn, Matt, Gilks, C. Blake
Publicado 2009

Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytes

por Milne, Katy, Alexander, Cheryl, Webb, John R, Sun, Winnie, Dillon, Kristy, Kalloger, Steve E, Gilks, C Blake, Clarke, Blaise, Köbel, Martin, Nelson, Brad H
Publicado 2012

Absence of BRCA/FMR1 Correlations in Women with Ovarian Cancers

por Gleicher, Norbert, McAlpine, Jessica N., Gilks, C. Blake, Kushnir, Vitaly A., Lee, Ho-Joon, Wu, Yan-Guang, Lazzaroni-Tealdi, Emanuela, Barad, David H.
Publicado 2014

Performance of the pattern‐based interpretation of p53 immunohistochemistry as a surrogate for TP53 mutations in vulvar squamous cell carcinoma

por Kortekaas, Kim E, Solleveld‐Westerink, Nienke, Tessier‐Cloutier, Basile, Rutten, Tessa A, Poelgeest, Mariëtte I E, Gilks, C Blake, Hoang, Lien N, Bosse, Tjalling
Publicado 2020

Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumours

por Kucab, Jill E, Lee, Cathy, Chen, Ching-Shih, Zhu, Jiuxiang, Gilks, C Blake, Cheang, Maggie, Huntsman, David, Yorida, Erika, Emerman, Joanne, Pollak, Michael, Dunn, Sandra E
Publicado 2005

Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists

por Soslow, Robert A., Tornos, Carmen, Park, Kay J., Malpica, Anais, Matias-Guiu, Xavier, Oliva, Esther, Parkash, Vinita, Carlson, Joseph, McCluggage, W. Glenn, Gilks, C. Blake
Publicado 2019

Claudin 4 Is Differentially Expressed between Ovarian Cancer Subtypes and Plays a Role in Spheroid Formation

por Boylan, Kristin L. M., Misemer, Benjamin, DeRycke, Melissa S., Andersen, John D., Harrington, Katherine M., Kalloger, Steve E., Gilks, C. Blake, Pambuccian, Stefan E., Skubitz, Amy P. N.
Publicado 2011